IL33466A - Cardio-active oxido-bufadienolides and process for their manufacture - Google Patents
Cardio-active oxido-bufadienolides and process for their manufactureInfo
- Publication number
- IL33466A IL33466A IL33466A IL3346669A IL33466A IL 33466 A IL33466 A IL 33466A IL 33466 A IL33466 A IL 33466A IL 3346669 A IL3346669 A IL 3346669A IL 33466 A IL33466 A IL 33466A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- oxido
- bufa
- cardio
- formula
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 5
- VPJPISZQCMUQFE-DWMPFVIVSA-N 5-[(8R,9S,10S,13R,14R,17S)-13-(hydroxymethyl)-10-methyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyran-2-one Chemical class OC[C@]12CC[C@H]3[C@@H](CCC4CCCC[C@]34C)[C@H]1CC[C@@H]2C=1C=CC(=O)OC=1 VPJPISZQCMUQFE-DWMPFVIVSA-N 0.000 title claims description 4
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- HAJGVUYNXHQLER-UHFFFAOYSA-N Bufadienolide Natural products O1C(=O)C=CC(C2C3C(C4C(C5CCCCC5CC4)CC3)CC2)=C1 HAJGVUYNXHQLER-UHFFFAOYSA-N 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- -1 acyloxy compound Chemical class 0.000 claims 1
- YBPMPRDOWHIVNA-XTBIJCDISA-N bufadienolide Chemical compound C=1([C@H]2CC[C@@H]3[C@H]4[C@@H]([C@]5(CCCCC5CC4)C)CC[C@@]32C)C=CC(=O)OC=1 YBPMPRDOWHIVNA-XTBIJCDISA-N 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 150000004965 peroxy acids Chemical class 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 27
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 238000004821 distillation Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- GLVYLTSKTCWWJR-UHFFFAOYSA-N 2-carbonoperoxoylbenzoic acid Chemical compound OOC(=O)C1=CC=CC=C1C(O)=O GLVYLTSKTCWWJR-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- VBTQNRFWXBXZQR-UHFFFAOYSA-N n-bromoacetamide Chemical compound CC(=O)NBr VBTQNRFWXBXZQR-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09F—DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
- G09F15/00—Boards, hoardings, pillars, or like structures for notices, placards, posters, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Theoretical Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19681812945 DE1812945C (de) | 1968-12-05 | Herzwirksame 4beta, 5beta 14beta, 15beta Dioxidobufadienohde |
Publications (2)
Publication Number | Publication Date |
---|---|
IL33466A0 IL33466A0 (en) | 1970-02-19 |
IL33466A true IL33466A (en) | 1973-05-31 |
Family
ID=5715380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL33466A IL33466A (en) | 1968-12-05 | 1969-12-01 | Cardio-active oxido-bufadienolides and process for their manufacture |
Country Status (9)
Country | Link |
---|---|
US (1) | US3681344A (en, 2012) |
AT (2) | AT301057B (en, 2012) |
BE (1) | BE742719A (en, 2012) |
DK (1) | DK123935B (en, 2012) |
ES (1) | ES374234A1 (en, 2012) |
FR (1) | FR2025439B1 (en, 2012) |
GB (1) | GB1288060A (en, 2012) |
IL (1) | IL33466A (en, 2012) |
NL (1) | NL6917924A (en, 2012) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3325484A (en) * | 1963-11-15 | 1967-06-13 | American Home Prod | Process for preparing periplogenia and intermediates secured therein |
-
1969
- 1969-11-28 NL NL6917924A patent/NL6917924A/xx unknown
- 1969-12-01 IL IL33466A patent/IL33466A/en unknown
- 1969-12-02 US US881581A patent/US3681344A/en not_active Expired - Lifetime
- 1969-12-04 ES ES374234A patent/ES374234A1/es not_active Expired
- 1969-12-04 DK DK643169AA patent/DK123935B/da unknown
- 1969-12-05 AT AT1089270A patent/AT301057B/de not_active IP Right Cessation
- 1969-12-05 FR FR696942080A patent/FR2025439B1/fr not_active Expired
- 1969-12-05 GB GB5961769A patent/GB1288060A/en not_active Expired
- 1969-12-05 BE BE742719D patent/BE742719A/xx unknown
- 1969-12-05 AT AT1136169A patent/AT293639B/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FR2025439B1 (en, 2012) | 1973-07-13 |
IL33466A0 (en) | 1970-02-19 |
BE742719A (en, 2012) | 1970-06-05 |
NL6917924A (en, 2012) | 1970-06-09 |
US3681344A (en) | 1972-08-01 |
AT301057B (de) | 1972-08-25 |
GB1288060A (en, 2012) | 1972-09-06 |
DE1812945A1 (de) | 1970-06-18 |
FR2025439A1 (en, 2012) | 1970-09-11 |
DK123935B (da) | 1972-08-21 |
AT293639B (de) | 1971-10-25 |
ES374234A1 (es) | 1971-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2824874A (en) | Reserpic acid and derivatives | |
Singh et al. | Structure and stereochemistry of paristerone, a novel phytoecdysone from the tubers of Paris polyphylla | |
US2864834A (en) | Pregnatetraenes and method of preparing the same | |
IL33466A (en) | Cardio-active oxido-bufadienolides and process for their manufacture | |
US3799933A (en) | Method of preparing new indolic derivatives usable for synthesizing dextro-rotary vincamine | |
US3133940A (en) | Process for the separation of delta-1, 4-3-keto steroid compounds from mixtures thereof with other 3-keto steroids | |
US3480621A (en) | Steroid ketal | |
US3639392A (en) | Cardioactive oxido-bufatrienolides | |
Mulchandani et al. | Physalin D, a New 13, 14–Seco–16, 24–Cyclo Steroid from Physalis minima | |
US3102145A (en) | Intermediate in the preparation of 19-nor-progesterone | |
Allison et al. | Modified steroid hormones—XLVII: Some further pentacyclic types | |
DE2442245A1 (de) | Verfahren zur reinigung der dimeren indolalkaloide vincristin, des-n-methylvinblastin und vinblastin | |
US3060169A (en) | Condensation products of glucosides with carbonyl compounds | |
US2593248A (en) | Androstatrienes and method of preparing the same | |
US2438715A (en) | Purification of dehydrocorticosterone acetate | |
US3347854A (en) | Preparation of 11beta-hydroxy-19-nor steroidal-delta1, 3, 5 (10), 6, 8-pentaenes | |
GB1574685A (en) | Vitamin d3 derivatives | |
US3146231A (en) | Ketals of 4, 6-androstadien-17beta-ol-3 ones and esters thereof | |
US3222361A (en) | 18-ethylenedioxy-17-isopregnenes and derivatives thereof | |
SU612635A3 (ru) | Способ получени 5 ,17 -диацетокси6 -хлор-2 ,3 ,16 ,17 диэпоксиандростана | |
US3366651A (en) | 6-chloro-6-dehydro-17alpha-(lower alkyl) progesterones | |
US3058976A (en) | 3, 3-dimethoxy-20-spirox-5(10)-ene-21-one and process of preparation | |
US3139427A (en) | 17alpha, 21-substituted methylenedioxy pregnadienes | |
US2990415A (en) | 9-substituted delta4-androstenes | |
US2438418A (en) | Process for the isolation of oleandrin |